Past investments

• AveXis
• Remix Therapeutics
• Karyopharm Therapeutics
• Olema Oncology
• Jounce Therapeutics
• Wave Life Sciences
• LifeMine Therapeutics
• Peloton Therapeutics
• 10X Genomics
• Ardelyx
• Adaptimmune
• Cullinan Oncology
• Kira Pharmaceuticals
• Generation Bio
• Relay Therapeutics
• Protagonist Therapeutics
• Decibel Therapeutics
• Alector
• Cue
• Orchard Therapeutics
• Crossover Health
• Audentes Therapeutics
• Tarsa Therapeutics
• Verona Pharma
• Aduro BioTech
• Juvenescence
• Genomics
• Intarcia Therapeutics
• Turning Point Therapeutics
• Akari Therapeutics
• Genapsys
• Cerevance
• SomaLogic
• Bit Bio
• Affinivax
• Fulcrum Therapeutics
• Inscripta
• Intellia Therapeutics
• Maze Therapeutics
• Replimune Group
• ALX Oncology
• WaveTec Vision
• Tempest Therapeutics
• evonetix
• HealthVerity
• ORIC Pharmaceuticals
• EverlyWell
• Tasso
• Vaxcyte
• Delfi Diagnostics
• Sequenta
• REGENXBIO
• Solid Biosciences
• Keros Therapeutics
• Nexvet
• Venatorx Pharmaceuticals
• Insitro
• VelosBio
• Mindstrong
• Kinnate Biopharma
• Kriya Therapeutics
• Twist Bioscience
• Aimmune Therapeutics
• Element Biosciences
• Pharvaris
• Arcus Biosciences
• DNAnexus
• Nurix Therapeutics
• Ivantis
• SAGE Therapeutics